Structural Heart Devices Global Market - Forecast to 2024

Publishing Date : July, 2018
Report Code : HCMD0133
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Structural heart devices has emerged as a new focus area of medical device manufacturers as the population of most developed and developing countries continue to become older and risk of cardiovascular diseases increase with aging. The cardiovascular diseases which also include structural heart diseases have become leading cause of death. It is projected that, with newfound prosperity due to globalization and industrialization has led to changing lifestyle leading to increasing risk of younger people developing cardiovascular diseases. The increased interest has led to development of new technologies and devices that are less invasive and address the need of treatment of patients who are considered too weak to withstand the trauma of an open heart surgery.

According to IQ4I Analysis, Structural heart device market is expected to grow at a medium double digit CAGR to reach $15,671.0 million by 2024. The structural heart device market is classified based on product, product type and geography. The Structural heart devices market in this report is segmented by Product, Product type and Geography. Structural heart devices by product are segmented into Repair devices and Replacement devices. Repair devices by product type is segmented into Surgical Heart Repair (Annuloplasty) and Transcatheter heart repair devices. Transcatheter heart repair devices are further classified as Valvuloplasty, Occluders, Transcatheter Mitral Valve Repair and Others (Chordal replacement in mitral valve repair, Transcatheter tricuspid valve repair and Ventricular remodelling). Replacement devices by product type are segmented into Surgical Valve Replacement and Transcatheter Valve Replacement. Surgical valve replacement devices are further sub-segmented into Mechanical valves and Tissue valves. Transcatheter Valve Replacement devices are sub-segmented into Transcatheter aortic valve replacement (TAVR), Transcatheter Mitral valve replacement (TMVR), Transcatheter pulmonary valve replacement (TPVR).

The structural heart devices global market is segmented into repair and replacement devices based on the products. The replacement devices segment held the largest market revenue in 2017 and expected to grow at a medium double digit CAGR from 2017 to 2024. In structural heart repair devices segment, transcatheter repair device held the largest share in 2017 and is projected to grow at a strong double digit CAGR from 2017 to 2024. Among transcatheter repair devices, Transcatheter mitral valve repair device held the largest share in 2017 and is projected to grow at a strong double digit CAGR from 2017 to 2024. The Structural heart Replacement segment is dominated by Transcatheter valve replacement that held largest share in 2017 and expected to grow at a strong double digit CAGR from 2017 to 2024. Among the Surgical valve replacement devices, Tissue valves held the largest share in 2017 and is expected to grow at a single digit CAGR from 2017 to 2024. Among the Transcatheter valve replacement devices, Transcatheter Aortic Valve Replacement (TAVR) devices held the largest share and expected to grow at a medium double digit CAGR from 2017 to 2024 and Transcatheter Mitral Valve Replacement (TMVR) devices is expected to grow at a strong double digit CAGR from 2017 to 2024.

The structural heart devices market by geography is divided into North America (U.S., Others), Europe (Germany, Italy, France, Others), Asia-pacific (Japan, China, Korea, Others) and Rest of the World (Brazil, Rest of Latin America, Middle East and Others).

North America region held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Among North America countries, U.S. held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Europe held the second largest share and is expected to grow at a medium double digit CAGR from 2017 to 2024. Among European countries, Germany held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Asia-Pacific is expected to grow at a strong double digit CAGR from 2017 to 2024. Among APAC countries, Japan held the highest share in 2017 and is expected to grow at a strong double digit CAGR from 2017 to 2024. RoW is expected to grow at a medium double digit CAGR from 2017 to 2024. Among RoW countries, Brazil held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024.

Some of the major players in structural heart devices market include Abbott laboratories (U.S.), Medtronic (Ireland), Boston Scientific (U.S.), Edward Lifesciences (U.S.), LivaNova (U.K.), Lepu Medicals (China), JenaValve Technologies GmbH (Germany), Braile biomedia (Brazil), Cryolife (U.S.), Labcore Laboratories ltd (Brazil).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Others
  • Europe
  • Germany
  • Italy
  • France
  • Others
  • Asia-Pacific 
  • Japan
  • China
  • Korea
  • Others
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East & Other

     

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN MINIMALLY INVASIVE SURGERY FOR STRUCTURAL HEART DISEASES
        • 3.3.1.2     TECHNOLOGY ADVANCEMENTS AND GROWING HEALTHCARE BUDGETARY ALLOCATION
        • 3.3.1.3     RISING GERIATRIC POPULATION WITH STRUCTURAL HEART DISEASES
        • 3.3.1.4     ACQUISITIONS TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
        • 3.3.1.5     VAST PIPELINE PRODUCTS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF THE STRUCTURAL HEART DEVICES
        • 3.3.2.2     LACK OF PATIENT AWARENESS AND HEALTHCARE INFRASTRUCTURE IN DEVELOPING COUNTRIES
        • 3.3.2.3     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.4     LACK OF SKILLED AND TRAINED PROFESSIONALS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
        • 3.4.1.3     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     JAPAN
      • 3.4.6     CHINA
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
    • 3.6     PATENT TRENDS
    • 3.7     TECHNOLOGICAL ADVANCEMENTS
      • 3.7.1     INTRODUCTION
      • 3.7.2     TISSUE ENGINEERING
      • 3.7.3     POLYMERIC HEART VALVES
      • 3.7.4     SUTURELESS AORTIC VALVE REPLACEMENT (SU-AVR) SYSTEM
      • 3.7.5     ENDOSCOPIC AORTIC VALVE REPLACEMENT (TEVAR) SYSTEM
      • 3.7.6     3-D PRINTED MODEL
    • 3.8     CLINICAL TRIALS
    • 3.9     PORTER’S FIVE FORCE ANALYSIS
      • 3.9.1     THREAT OF NEW ENTRANTS
      • 3.9.2     THREAT OF SUBSTITUTES
      • 3.9.3     BARGAINING POWER OF SUPPLIERS
      • 3.9.4     BARGAINING POWER OF BUYERS
      • 3.9.5     COMPETITIVE RIVALRY
    • 3.10     SUPPLY CHAIN ANALYSIS
    • 3.11     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.11.1     STRUCTURAL HEART DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.11.2     MARKET SHARE ANALYSIS OF ANNULOPLASTY REPAIR DEVICES BY MAJOR PLAYERS
      • 3.11.3     MARKET SHARE ANALYSIS OF OCCLUDERS BY MAJOR PLAYERS
      • 3.11.4     MARKET SHARE ANALYSIS OF MECHANICAL VALVE REPLACEMENT DEVICES BY MAJOR PLAYERS
      • 3.11.5     MARKET SHARE ANALYSIS OF TISSUE VALVE REPLACEMENT DEVICES BY MAJOR PLAYERS
      • 3.11.6     MARKET SHARE ANALYSIS OF TRANSCATHETER AORTIC VALVE REPLACEMENT BY MAJOR PLAYERS
    • 3.12     STRUCTURAL HEART DISEASES U.S. MARKET PENETRATION, PREVALENCE, OPPORTUNITY AND NUMBER OF PROCEDURES PERFORMED
    • 3.13     STRUCTURAL HEART DEVICES NUMBER OF UNITS BY REGION
      • 3.13.1     OCCLUDERS NUMBER OF UNITS BY REGION
      • 3.13.2     TRANSCATHETER MITRAL VALVE REPAIR DEVICES NUMBER OF UNITS BY REGION
      • 3.13.3     SURGICAL VALVE REPARI - ANNULOPLASTY DEVICES NUMBER OF UNITS BY REGION
      • 3.13.4     TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) DEVICES NUMBER OF UNITS BY REGION
      • 3.13.5     TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR) DEVICES NUMBER OF UNITS BY REGION
      • 3.13.6     TRANSCATHETER PULMONARY VALVE REPLACEMENT (TPVR) DEVICES NUMBER OF UNITS BY REGION
    • 3.14     STRUCTURAL HEART DEVICES COMPANY COMPARISON TABLE BY PRODUCTS
      • 3.14.1     AORTIC VALVE DEVICES COMPANY COMPARISON TABLE BY PRODUCTS
      • 3.14.2     MITRAL VALVE DEVICES COMPANY COMPARISON TABLE BY PRODUCTS
      • 3.14.3     CLOSURE DEVICES (OCCLUDERS) COMPANY COMPARISON TABLE BY PRODUCTS
      • 3.14.4     OTHER STRUCTURAL HEART DEVICES COMPANY COMPARISON TABLE BY PRODUCTS
  • 4     STRUCTURAL HEART DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     STRUCTURAL HEART REPAIR DEVICES
      • 4.2.1     SURGICAL HEART REPAIR (ANNULOPLASTY)
      • 4.2.2     TRANSCATHETER HEART REPAIR DEVICES
        • 4.2.2.1     VALVULOPLASTY
        • 4.2.2.2     OCCLUDERS
        • 4.2.2.3     TRANSCATHETER MITRAL VALVE REPAIR
        • 4.2.2.4     OTHER TRANSCATHETER REPAIR DEVICES
    • 4.3     STRUCTURAL HEART VALVE REPLACEMENT DEVICES
      • 4.3.1     INTRODUCTION
      • 4.3.2     SURGICAL VALVE REPLACEMENT DEVICES
        • 4.3.2.1     MECHANICAL HEART VALVES
        • 4.3.2.2     TISSUE HEART VALVES (BIOLOGICAL VALVES)
      • 4.3.3     TRANSCATHETER VALVE REPLACEMENT DEVICES
        • 4.3.3.1     TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
        • 4.3.3.2     TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR)
        • 4.3.3.3     TRANSCATHETER PULMONARY VALVE REPLACEMENT (TPVR)
  • 5     REGIONAL ANALYSIS
    • 5.1     INTRODUCTION
    • 5.2     NORTH AMERICA
      • 5.2.1     U.S.
      • 5.2.2     OTHERS
    • 5.3     EUROPE
      • 5.3.1     GERMANY
      • 5.3.2     ITALY
      • 5.3.3     FRANCE
      • 5.3.4     OTHERS
    • 5.4     APAC
      • 5.4.1     JAPAN
      • 5.4.2     CHINA
      • 5.4.3     KOREA
      • 5.4.4     OTHERS
    • 5.5     ROW
      • 5.5.1     BRAZIL
      • 5.5.2     REST OF LATAM
      • 5.5.3     MIDDLE EAST & OTHERS
  • 6     COMPETITIVE LANDSCAPE
    • 6.1     INTRODUCTION
    • 6.2     APPROVALS
    • 6.3     ACQUISITIONS
    • 6.4     NEW PRODUCT LAUNCH
    • 6.5     AGREEMENTS
    • 6.6     OTHER DEVELOPMENTS
  • 7     MAJOR COMPANIES
    • 7.1     ABBOTT LABORATORIES
      • 7.1.1     OVERVIEW
      • 7.1.2     FINANCIALS
      • 7.1.3     PRODUCT PORTFOLIO
      • 7.1.4     KEY DEVELOPMENTS
      • 7.1.5     BUSINESS STRATEGY
      • 7.1.6     SWOT ANALYSIS
    • 7.2     BOSTON SCIENTIFIC CORPOARTION
      • 7.2.1     OVERVIEW
      • 7.2.2     FINANCIALS
      • 7.2.3     PRODUCT PORTFOLIO
      • 7.2.4     KEY DEVELOPMENTS
      • 7.2.5     BUSINESS STRATEGY
      • 7.2.6     SWOT ANALYSIS
    • 7.3     BRAILE BIOMEDICA
      • 7.3.1     OVERVIEW
      • 7.3.2     FINANCIALS
      • 7.3.3     PRODUCT PORTFOLIO
      • 7.3.4     KEY DEVELOPMENTS
      • 7.3.5     BUSINESS STRATEGY
      • 7.3.6     SWOT ANALYSIS
    • 7.4     CRYOLIFE, INC.
      • 7.4.1     OVERVIEW
      • 7.4.2     FINANCIALS
      • 7.4.3     PRODUCT PORTFOLIO
      • 7.4.4     KEY DEVELOPMENTS
      • 7.4.5     BUSINESS STRATEGY
      • 7.4.6     SWOT ANALYSIS
    • 7.5     EDWARDS LIFESCIENCES CORP.
      • 7.5.1     OVERVIEW
      • 7.5.2     FINANCIALS
      • 7.5.3     PRODUCT PORTFOLIO
      • 7.5.4     KEY DEVELOPMENTS
      • 7.5.5     BUSINESS STRATEGY
      • 7.5.6     SWOT ANALYSIS
    • 7.6     JENAVALVE TECHNOLOGY
      • 7.6.1     OVERVIEW
      • 7.6.2     FINANCIALS
      • 7.6.3     PRODUCT PORTFOLIO
      • 7.6.4     KEY DEVELOPMENTS
      • 7.6.5     BUSINESS STRATEGY
      • 7.6.6     SWOT ANALYSIS
    • 7.7     LABCOR LABORATORIOS LTDA.
      • 7.7.1     OVERVIEW
      • 7.7.2     FINANCIALS
      • 7.7.3     PRODUCT PORTFOLIO
      • 7.7.4     KEY DEVELOPMENTS
      • 7.7.5     BUSINESS STRATEGY
      • 7.7.6     SWOT ANALYSIS
    • 7.8     LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
      • 7.8.1     OVERVIEW
      • 7.8.2     FINANCIALS
      • 7.8.3     PRODUCT PORTFOLIO
      • 7.8.4     KEY DEVELOPMENTS
      • 7.8.5     BUSINESS STRATEGY
      • 7.8.6     SWOT ANALYSIS
    • 7.9     LIVANOVA PLC (SORIN GROUP)
      • 7.9.1     OVERVIEW
      • 7.9.2     FINANCIALS
      • 7.9.3     PRODUCT PORTFOLIO
      • 7.9.4     KEY DEVELOPMENTS
      • 7.9.5     BUSINESS STRATEGY
      • 7.9.6     SWOT ANALYSIS
    • 7.10     MEDTRONIC, PLC
      • 7.10.1     OVERVIEW
      • 7.10.2     FINANCIALS
      • 7.10.3     PRODUCT PORTFOLIO
      • 7.10.4     KEY DEVELOPMENTS
      • 7.10.5     BUSINESS STRATEGY
      • 7.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     STRUCTURAL HEART DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 2     OCCLUDERS NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 3     TRANSCATHETER MITRAL VALVE REPAIR DEVICES NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 4     ANNULOPLASTY DEVICES NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 5     TAVR DEVICES NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 6     TMVR DEVICES NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 7     TPVR DEVICES NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 8     STRUCTURAL HEART DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 9     STRUCTURAL HEART DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 10     STRUCTURAL HEART REPAIR DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 11     STRUCTURAL HEART REPAIR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 12     STRUCTURAL HEART REPAIR (ANNULOPLASTY) GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 13     TRANSCATHETER HEART REPAIR DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 14     TRANSCATHETER HEART REPAIR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 15     VALVULOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 16     OCCLUDERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 17     TRANSCATHETER MITRAL VALVE REPAIR GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 18     OTHER TRANSCATHETER REPAIR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 19     STRUCTURAL HEART VALVE REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 20     STRUCTURAL HEART VALVE REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 21     SURGICAL VALVE REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 22     SURGICAL VALVE REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 23     MECHANICAL HEART VALVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 24     TISSUE HEART VALVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 25     TRANSCATHETER VALVE REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 26     TRANSCATHETER VALVE REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 27     TRANSCATHETER AORTIC VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 28     TRANSCATHETER MITRAL VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 29     TRANSCATHETER PULMONARY VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 30     STRUCTURAL HEART DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 31     NORTH AMERICA STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 32     NORTH AMERICA STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 33     NORTH AMERICA TRANSCATHETER HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 34     NORTH AMERICA STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 35     NORTH AMERICA SURGICAL VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 36     NORTH AMERICA TRANSCATHETER VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 37     NORTH AMERICA STRUCTURAL HEART DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 38     NORTH AMERICA TAVR MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 39     EUROPE STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 40     EUROPE STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 41     EUROPE TRANSCATHETER HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 42     EUROPE STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 43     EUROPE SURGICAL VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 44     EUROPE TRANSCATHETER VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 45     EUROPE STRUCTURAL HEART DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 46     EUROPE TAVR MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 47     APAC STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 48     APAC STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 49     APAC TRANSCATHETER HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 50     APAC STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 51     APAC SURGICAL VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 52     APAC TRANSCATHETER VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 53     APAC STRUCTURAL HEART DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 54     APAC TAVR MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 55     ROW STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 56     ROW STRUCTUR HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 57     ROW TRANSCATHETER HEART REPAIR DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 58     ROW STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 59     ROW SURGICAL VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 60     ROW TRANSCATHETER VALVE REPLACEMENT MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 61     ROW STRUCTURAL HEART DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 62     ROW TAVR MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 63     APPROVALS (2016 - 2018)
      • TABLE 64     ACQUISITIONS (2016 - 2018)
      • TABLE 65     NEW PRODUCT LAUNCH (2016 - 2018)
      • TABLE 66     AGREEMENTS (2016 - 2018)
      • TABLE 67     OTHER DEVELOPMENTS (2016 - 2018)
      • TABLE 68     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 69     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 70     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 71     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 72     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 73     BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR, BY SEGMNETS, (2015-2017) ($MN)
      • TABLE 74     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 75     CRYOLIFE, INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 76     CRYOLIFE, INC.: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 77     CRYOLIFE, INC.: TOTAL REVENUE, BY PRODUCTS, (2015-2017) ($MN)
      • TABLE 78     CRYOLIFE, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 79     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 80     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 81     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 82     LIVANOVA PLC: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
      • TABLE 83     LIVANOVA PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 84     LIVANOVA PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 85     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017*) ($MN)
      • TABLE 86     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017*) ($MN)
      • TABLE 87     MEDTRONIC, PLC: CARDIAC & VASCULAR TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017*) ($MN)
      • TABLE 88     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017*) ($MN)

      LIST OF FIGURES

      • FIGURE 1     STRUCTURAL HEART DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: STRUCTURAL HEART DEVICES GLOBAL MARKET
      • FIGURE 3     STRUCTURAL HEART DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     STRUCTURAL HEART DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     STRUCTURAL HEART DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     STRUCTURAL HEART DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     STRUCTURAL HEART DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2014–2018)
      • FIGURE 9     STRUCTURAL HEART DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     STRUCTURAL HEART DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     STRUCTURAL HEART DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 12     ANNULOPLASTY REPAIR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 13     CLOSURE DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 14     MECHANICAL VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 15     TISSUE VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 16     TAVR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 17     STRUCTURAL HEART DISEASES U.S. MARKET PENETRATION, OPPORTUNITY V/S NUMBER OF PROCEDURES PEFORMED, (2017) (NO’S)
      • FIGURE 18     STRUCTURAL HEART DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2017 V/S 2024) (%)
      • FIGURE 19     STRUCTURAL HEART DEVICES GLOBAL MARKET SHARE, BY REGION (2017 V/S 2024) (%)
      • FIGURE 20     STRUCTURAL HEART REPAIR DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2017) ($MN)
      • FIGURE 21     STRUCTURAL HEART REPAIR DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 22     STRUCTURAL HEART REPAIR (ANNULOPLASTY) GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 23     TRANSCATHETER HEART REPAIR DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 24     TRANSCATHETER HEART REPAIR DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 25     VALVULOPLASTY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 26     OCCLUDERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 27     TRANSCATHETER MITRAL VALVE REPAIR GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 28     OTHER TRANSCATHETER REPAIR DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 29     STRUCTURAL HEART VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2017 V/S 2024) (%)
      • FIGURE 30     STRUCTURAL HEART VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 31     SURGICAL VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2017 V/S 2024) (%)
      • FIGURE 32     SURGICAL VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 33     TISSUE HEART VALVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 34     TRANSCATHETER VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2017 V/S 2024) (%)
      • FIGURE 35     TRANSCATHETER VALVE REPLACEMENT DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 36     TRANSCATHETER AORTIC VALVE REPLACEMENT GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 37     TRANSCATHETER MITRAL VALVE REPLACEMENT GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 38     TRANSCATHETER PULMONARY VALVE REPLACEMENT GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 39     STRUCTURAL HEART DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%)
      • FIGURE 40     NORTH AMERICA STRUCTURAL HEART REPAIR MARKET SHARE, BY PRODUCT TYPE AND TRANSCATHETER REPAIR, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 41     NORTH AMERICA STRUCTURAL HEART REPLACEMENT MARKET SHARE, BY PRODUCT TYPE, SURGICAL AND TRANSCATHETER VALVE REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 42     NORTH AMERICA STRUCTURAL HEART DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 43     U.S. STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 44     OTHER NORTH AMERICA STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 45     EUROPE STRUCTURAL HEART REPAIR MARKET SHARE, BY PRODUCT TYPE AND TRANSCATHETER REPAIR, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 46     EUROPE STRUCTURAL HEART REPLACEMENT MARKET SHARE, BY PRODUCT TYPE, SURGICAL AND TRANSCATHETER VALVE REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 47     EUROPE STRUCTURAL HEART DEVICES SHARE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 48     GERMANY STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 49     ITALY STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 50     FRANCE STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 51     OTHER EUROPE STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 52     APAC STRUCTURAL HEART REPAIR MARKET SHARE, BY PRODUCT TYPE AND TRANSCATHETER REPAIR, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 53     APAC STRUCTURAL HEART REPLACEMENT MARKET SHARE, BY PRODUCT TYPE, SURGICAL AND TRANSCATHETER VALVE REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 54     APAC STRUCTURAL HEART DEVICES SHARE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 55     JAPAN STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 56     CHINA STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 57     KOREA STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 58     OTHER APAC STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 59     ROW STRUCTURAL HEART REPAIR MARKET SHARE, BY PRODUCT TYPE AND TRANSCATHETER REPAIR, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 60     ROW STRUCTURAL HEART REPLACEMENT MARKET SHARE, BY PRODUCT TYPE, SURGICAL AND TRANSCATHETER VALVE REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) (%)
      • FIGURE 61     ROW STRUCTURAL HEART DEVICES SHARE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 62     BRAZIL STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 63     REST OF LATAM STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 64     MIDDLE EAST & OTHERS STRUCTURAL HEART DEVICES MARKET REVENUE, BY PRODUCT, REPAIR AND REPLACEMENT, BY PRODUCT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 65     KEY GROWTH STRATEGIES, (2016-2018)
      • FIGURE 66     SWOT: ABBOTT LABORATORIES
      • FIGURE 67     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 68     SWOT: BRAILE BIOMEDICA
      • FIGURE 69     SWOT: CRYOLIFE, INC
      • FIGURE 70     SWOT: EDWARDS LIFESCIENCES
      • FIGURE 71     SWOT: JENAVALVE TECHNOLOGY
      • FIGURE 72     SWOT: LABCOR LABORATORIES LTDA
      • FIGURE 73     SWOT: LEPU MEDICAL TECHNOLOGY CO., LTD.
      • FIGURE 74     SWOT: LIVANOVA, PLC
      • FIGURE 75     SWOT: MEDTRONIC, PLC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     AFFLUENT MEDICAL
      • 3     ATRICURE
      • 4     BALTON SP. Z O.O.
      • 5     BECTON DICKINSON (C.R. BARD)
      • 6     BIOSTABLE SCIENCE AND ENGINEERING
      • 7     BIOVENTRIX, INC
      • 8     BOSTON SCIENTIFIC
      • 9     BRAILE BIO MEDICA
      • 10     CARDIAC DIMENSIONS, INC.
      • 11     CARDIOKINETIX, INC.
      • 12     CARDIOSOLUTIONS, INC
      • 13     CEPHEA VALVE TECHNOLOGIES
      • 14     CLARET MEDICAL
      • 15     COLIBRI HEART VALVE, LLC
      • 16     COMED BV
      • 17     COOK MEDICALS LLC
      • 18     CRYO LIFE, INC.
      • 19     EDWARD LIFESCIECES
      • 20     GUIDED DELIVERY SYSTEMS, INC.
      • 21     HANCOCK JAFFE
      • 22     HEART LEAFLET TECHNOLOGIES
      • 23     HIGHLIFE SAS
      • 24     INTERVALVE, INC
      • 25     JC MEDICAL INC.
      • 26     JENAVALVE TECHNOLOGY GMBH
      • 27     LABCOR LABORATÓRIOS LTDA.
      • 28     LEMAN CARDIOVASCULAR
      • 29     LEPU MEDICAL
      • 30     LIVANOVA PLC
      • 31     MARDIL MEDICALS INC.
      • 32     MEDTENTIA INTERNATIONAL LTD OY
      • 33     MEDTRONIC PLC
      • 34     MICARDIA CORPORATION
      • 35     MICRO INTERVENTIONAL DEVICES
      • 36     MITRALIGN
      • 37     MITRASSIST
      • 38     NAVIGATE CARDIAC STRUCTURES INC.
      • 39     NEOCHORD INC.
      • 40     NOVOSTIA SA
      • 41     NUMED, INC.
      • 42     NVT MED AG
      • 43     OCCLUTECH INTERNATIONAL AB
      • 44     OSYPKA AG
      • 45     PHOENIX CARDIAC DEVICES INC.
      • 46     SECANT MEDICAL
      • 47     STRAIT ACCESS TECHNOLOGIES PVT LTD
      • 48     THUBRIKAR AORTIC VALVE, INC.
      • 49     TORAY INDUSTRIES, INC.
      • 50     TRANSCATHETER TECHNOLOGIES GMBH
      • 51     TRANSCARDIAC THERAPEUTICS, LLC
      • 52     TTKCHITRA HEARTVALVE
      • 53     VALCARE MEDICAL
      • 54     VENUS MEDTECH (HANGZHOU) INC.
      • 55     W. L. GORE AND ASSOCIATES
      • 56     XELTIS AG
      • 57     XUZHOU YATAI SCIENTIFIC CO.,LTD